Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -606.7%
March 31, 2026 -1.37K%
December 31, 2025 -2.47K%
September 30, 2025 -1.49K%
June 30, 2025 -1.36K%
March 31, 2025 -497.4%
December 31, 2024 -833.3%
September 30, 2024 -637.9%
June 30, 2024 -1.43K%
March 31, 2024
December 31, 2023 -475.6%
September 30, 2023 -833.3%
June 30, 2023 -234.1%
Date Value
March 31, 2023 -327.0%
December 31, 2022 -495.4%
September 30, 2022 -196.6%
June 30, 2022 -228.2%
March 31, 2022 -386.8%
December 31, 2021 -511.5%
September 30, 2021 -378.3%
June 30, 2021 -940.0%
March 31, 2021 -1.48K%
December 31, 2020 -3.32K%
September 30, 2020 -3.96K%
June 30, 2020 -3.27K%
March 31, 2020 -2.78K%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Myriad Genetics, Inc. 62.51%
BioRestorative Therapies, Inc. -157.8%
CareDx, Inc. 73.37%
Natera, Inc. 63.70%
Exagen, Inc. 61.27%

Gross Profit Margin (Quarterly) Related Metrics